Cite
HARVARD Citation
de la Rubia, J. et al. (2019). Efficacy and tolerability of EH301 for amyotrophic lateral sclerosis: a randomized, double-blind, placebo-controlled human pilot study. Amyotrophic lateral sclerosis and frontotemporal degeneration. 20 (1), pp. 115-122. [Online].